During the past decade, Medaimun GmbH conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medaimun GmbH" #1 sponsor was "AbbVie" with 1 trials, followed by "Aimmune Therapeutics, Inc." with 1 trials sponsored, "Allergy Therapeutics" with 1 trials sponsored, "HAL Allergy" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medaimun GmbH" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Medaimun GmbH" are "Asthma" (2 trials), "Allergic Asthma" (1 trials), "Allergic Rhinitis" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials) and "Allergy to House Dust Mite" (1 trials). Many other conditions were trialed in "Medaimun GmbH" in a lesser frequency.

Most popular intervention types in "Medaimun GmbH" are "Drug" (5 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AR101 powder provided in capsules & sachets" (1 trials), "Lebrikizumab" (1 trials), "PQ Grass" (1 trials) and "PURETHAL Grasses, 20.000 AUM/ml" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medaimun GmbH" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Medaimun GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Medaimun GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medaimun GmbH, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".